Tardif JC - Search Results

1

The interleukin-1β modulator gevokizumab reduces neointimal proliferation and improves reendothelialization in a rat carotid denudation model.

Roubille F, Busseuil D, Shi Y, Nachar W, Mihalache-Avram T, Mecteau M, Gillis MA, Brand G, Théberge-Julien G, Brodeur MR, Kernaleguen AE, Gombos M, Rhéaume E, Tardif JC. Roubille F, et al. Among authors: tardif jc. Atherosclerosis. 2014 Oct;236(2):277-85. doi: 10.1016/j.atherosclerosis.2014.07.012. Epub 2014 Jul 21. Atherosclerosis. 2014. PMID: 25108619

2

Dynamic nature of atrial fibrillation substrate during development and reversal of heart failure in dogs.

Shinagawa K, Shi YF, Tardif JC, Leung TK, Nattel S. Shinagawa K, et al. Among authors: tardif jc. Circulation. 2002 Jun 4;105(22):2672-8. doi: 10.1161/01.cir.0000016826.62813.f5. Circulation. 2002. PMID: 12045175

3

Enalapril effects on atrial remodeling and atrial fibrillation in experimental congestive heart failure.

Shi Y, Li D, Tardif JC, Nattel S. Shi Y, et al. Among authors: tardif jc. Cardiovasc Res. 2002 May;54(2):456-61. doi: 10.1016/s0008-6363(02)00243-2. Cardiovasc Res. 2002. PMID: 12062350

4

Dissociation between ionic remodeling and ability to sustain atrial fibrillation during recovery from experimental congestive heart failure.

Cha TJ, Ehrlich JR, Zhang L, Shi YF, Tardif JC, Leung TK, Nattel S. Cha TJ, et al. Among authors: tardif jc. Circulation. 2004 Jan 27;109(3):412-8. doi: 10.1161/01.CIR.0000109501.47603.0C. Epub 2004 Jan 12. Circulation. 2004. PMID: 14718405

5

Antioxidants and atherosclerosis: emerging drug therapies.

Tardif JC. Tardif JC. Curr Atheroscler Rep. 2005 Feb;7(1):71-7. doi: 10.1007/s11883-005-0078-1. Curr Atheroscler Rep. 2005. PMID: 15683606 Review.

6

Biventricular diastolic filling patterns after coronary artery bypass graft surgery.

Shi Y, Denault AY, Couture P, Butnaru A, Carrier M, Tardif JC. Shi Y, et al. Among authors: tardif jc. J Thorac Cardiovasc Surg. 2006 May;131(5):1080-6. doi: 10.1016/j.jtcvs.2006.01.015. J Thorac Cardiovasc Surg. 2006. PMID: 16678593 Free article.

7

Effects of the antioxidant succinobucol (AGI-1067) on human atherosclerosis in a randomized clinical trial.

Tardif JC, Grégoire J, L'Allier PL, Ibrahim R, Anderson TJ, Reeves F, Title LM, Schampaert E, LeMay M, Lespérance J, Scott R, Guertin MC, Brennan ML, Hazen SL, Bertrand OF; CART-2 Investigators. Tardif JC, et al. Atherosclerosis. 2008 Mar;197(1):480-6. doi: 10.1016/j.atherosclerosis.2006.11.039. Epub 2007 Jan 9. Atherosclerosis. 2008. PMID: 17214993 Clinical Trial.

8

[A new type of medical treatment could lead to regression of aortic valve stenosis].

Busseuil D, Rhéaume E, Tardif JC. Busseuil D, et al. Among authors: tardif jc. Med Sci (Paris). 2008 Aug-Sep;24(8-9):675-6. doi: 10.1051/medsci/20082489675. Med Sci (Paris). 2008. PMID: 18789203 Free article. French. No abstract available.

9

High-density lipoprotein/apolipoprotein A-I infusion therapy.

Tardif JC, Heinonen T, Noble S. Tardif JC, et al. Curr Atheroscler Rep. 2009 Jan;11(1):58-63. doi: 10.1007/s11883-009-0009-7. Curr Atheroscler Rep. 2009. PMID: 19080729 Review.

10

Hemodynamic and cardiac effects of chronic eprosartan and moxonidine therapy in stroke-prone spontaneously hypertensive rats.

Mukaddam-Daher S, Menaouar A, Paquette PA, Jankowski M, Gutkowska J, Gillis MA, Shi YF, Calderone A, Tardif JC. Mukaddam-Daher S, et al. Among authors: tardif jc. Hypertension. 2009 May;53(5):775-81. doi: 10.1161/HYPERTENSIONAHA.108.126524. Epub 2009 Mar 9. Hypertension. 2009. PMID: 19273740

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

794 results

Search Page